CHAMPIONS ONCOLOGY, INC. — Director's Dealing 2021

Oct 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK: 0000771856
Period of Report: 2021-10-15

Reporting Person: SIDRANSKY DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-15	Common Stock	M	16667	$1.59	Acquired	764901	Direct
2021-10-15	Common Stock	F	2629	$10.08	Acquired	762272	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-15	Option to purchase Common Stock	$1.59	A	16667	Acquired	2021-11-01	Common Stock (16667.0)	Direct

Footnotes

F1: Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 15, 2021.

F2: The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively.